
    
      This is an multi-center,single-blinded,parallel-group,dose-finding study using Remimazolam or
      propofol for sedation in patients undergoing diagnostic upper GI endoscopy.Subjects are
      randomized to different treatment groups (including 4 for Remimazolam Tosilate and 1 for
      propofol).Lidocaine and fentanyl are permitted during a diagnostic upper GI
      endoscopy.Efficacy and safety profiles of Remimazolam Tosilate are to be evaluated.
    
  